Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
Finasteride is primarily used to treat benign prostatic hyperplasia (BPH) and male androgenetic alopecia (MAA). Five-alpha reductase inhibitors (5α-RIs) could induce male sexual dysfunction due to their effects on testosterone and dihydrotestos-terone. There is evidence suggesting that 5α-RIs may in...
Main Authors: | Yu Seob Shin, Keshab Kumar Karna, Bo Ram Choi, Jong Kwan Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society for Sexual Medicine and Andrology
2019-05-01
|
Series: | The World Journal of Men's Health |
Subjects: |
Similar Items
-
Frozen-Thawed Sperm Analysis of Benign Prostatic Hyperplasia Dogs Treated With Finasteride
by: Renato Bueno Flores, et al.
Published: (2022-06-01) -
The impact of combination therapy of Croton membranaceus and finasteride on benign prostatic hyperplasia (BHP) histo-morphology
by: George A. Asare, et al.
Published: (2024-05-01) -
PHARMACOTHERAPY ALOPECIA ANDROGENETIC IN MEN
by: Riezky Januar Pramitha, et al.
Published: (2013-03-01) -
Prospective double-blind randomized controlled trial of terazosin, finasteride and allylestrenol in the management of benign prostatic hyperplasia
by: Madhu S Agrawal, et al.
Published: (2001-01-01) -
Algorithm for a short course of finasteride in patients with benign prostatic hyperplasia before transurethral resection of the prostate
by: KB Kolontarev, et al.
Published: (2014-12-01)